Sanne H.B. van Dijk MSc, BA , Marjolein G.J. Brusse-Keizer PhD , Tanja Effing PhD , Eline H. Ploumen MD, PhD , Paul D.L.P.M. van der Valk MD, PhD , Job van der Palen PhD , Carine J.M. Doggen PhD , Anke Lenferink PhD
{"title":"The interplay between symptom deterioration of chronic obstructive pulmonary disease and chronic heart failure","authors":"Sanne H.B. van Dijk MSc, BA , Marjolein G.J. Brusse-Keizer PhD , Tanja Effing PhD , Eline H. Ploumen MD, PhD , Paul D.L.P.M. van der Valk MD, PhD , Job van der Palen PhD , Carine J.M. Doggen PhD , Anke Lenferink PhD","doi":"10.1016/j.hrtlng.2025.06.004","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Chronic obstructive pulmonary disease (COPD) and chronic heart failure (CHF) commonly co-exist and share symptoms, which complicates disease management. It is unclear how COPD and CHF deterioration inter(re)act.</div></div><div><h3>Objective</h3><div>This study aimed to assess the interplay between COPD and CHF deterioration on group and individual level.</div></div><div><h3>Methods</h3><div>Total daily COPD- and CHF-symptom intensity scores (SIS) were calculated based on increased symptoms of COPD (dyspnea, sputum purulence and color, coughing, wheezing, fever) and CHF (sudden weight increase, swelling, nocturnal dyspnea), as reported by patients in one-year daily symptom diaries. The COPD-CHF interplay was assessed visually and statistically (on group and individual level) by mixed models.</div></div><div><h3>Results</h3><div>From a multicenter trial (<em>N</em> = 201), 33 patients with COPD and CHF (72.4 ± 7.8 years, 24 men (72.7 %)) were included. On group level, increased CHF-SIS positively predicted next day’s COPD-SIS (<em>p</em> = 0.02). However, on individual level, the direction and strength of the associations between CHF-SIS and subsequent COPD-SIS varied substantially. Vice versa, increased COPD-SIS also predicted next day’s CHF-SIS on group level (<em>p</em> < 0.001). On individual level, the direction of the associations varied less, although strength differed from negligible to strongly positive.</div></div><div><h3>Conclusions</h3><div>On group level, CHF deterioration predicts an increase in next day’s COPD symptom score, as well as vice versa. Individual-level associations reinforce the group-level results for COPD provoking CHF symptoms, but not for CHF provoking COPD symptoms. The COPD-CHF interplay should be monitored and, if present, acted upon to optimize patient disease management.</div></div>","PeriodicalId":55064,"journal":{"name":"Heart & Lung","volume":"74 ","pages":"Pages 57-64"},"PeriodicalIF":2.6000,"publicationDate":"2025-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Heart & Lung","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0147956325001463","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Chronic obstructive pulmonary disease (COPD) and chronic heart failure (CHF) commonly co-exist and share symptoms, which complicates disease management. It is unclear how COPD and CHF deterioration inter(re)act.
Objective
This study aimed to assess the interplay between COPD and CHF deterioration on group and individual level.
Methods
Total daily COPD- and CHF-symptom intensity scores (SIS) were calculated based on increased symptoms of COPD (dyspnea, sputum purulence and color, coughing, wheezing, fever) and CHF (sudden weight increase, swelling, nocturnal dyspnea), as reported by patients in one-year daily symptom diaries. The COPD-CHF interplay was assessed visually and statistically (on group and individual level) by mixed models.
Results
From a multicenter trial (N = 201), 33 patients with COPD and CHF (72.4 ± 7.8 years, 24 men (72.7 %)) were included. On group level, increased CHF-SIS positively predicted next day’s COPD-SIS (p = 0.02). However, on individual level, the direction and strength of the associations between CHF-SIS and subsequent COPD-SIS varied substantially. Vice versa, increased COPD-SIS also predicted next day’s CHF-SIS on group level (p < 0.001). On individual level, the direction of the associations varied less, although strength differed from negligible to strongly positive.
Conclusions
On group level, CHF deterioration predicts an increase in next day’s COPD symptom score, as well as vice versa. Individual-level associations reinforce the group-level results for COPD provoking CHF symptoms, but not for CHF provoking COPD symptoms. The COPD-CHF interplay should be monitored and, if present, acted upon to optimize patient disease management.
期刊介绍:
Heart & Lung: The Journal of Cardiopulmonary and Acute Care, the official publication of The American Association of Heart Failure Nurses, presents original, peer-reviewed articles on techniques, advances, investigations, and observations related to the care of patients with acute and critical illness and patients with chronic cardiac or pulmonary disorders.
The Journal''s acute care articles focus on the care of hospitalized patients, including those in the critical and acute care settings. Because most patients who are hospitalized in acute and critical care settings have chronic conditions, we are also interested in the chronically critically ill, the care of patients with chronic cardiopulmonary disorders, their rehabilitation, and disease prevention. The Journal''s heart failure articles focus on all aspects of the care of patients with this condition. Manuscripts that are relevant to populations across the human lifespan are welcome.